
Dihydrotestosterone(DHT)
CAS No. 521-18-6
Dihydrotestosterone(DHT)( androstanolone | stanolone | 5α-DHT )
Catalog No. M20270 CAS No. 521-18-6
Dihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 66 | In Stock |
![]() ![]() |
25MG | 126 | In Stock |
![]() ![]() |
50MG | 212 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameDihydrotestosterone(DHT)
-
NoteResearch use only, not for human use.
-
Brief DescriptionDihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
-
DescriptionDihydrotestosterone is a potent androgenic metabolite of testosterone. It is an agonist of the androgen receptor.
-
In Vitro——
-
In Vivo——
-
Synonymsandrostanolone | stanolone | 5α-DHT
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
RecptorAndrogen Receptor
-
Research AreaMetabolic Disease
-
IndicationHypogonadism
Chemical Information
-
CAS Number521-18-6
-
Formula Weight290.44
-
Molecular FormulaC19H30O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL (172.15 mM);Ethanol: 50 mg/mL (172.15 mM);Water:Insoluble
-
SMILES[H][C@@]12CC[C@H](O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)CC[C@]12C
-
Chemical Name5-alpha-Androstan-3-one 17-beta-hydroxy-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zheng Y et al. Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells. Endocr Relat Cancer. 2011 Jul 4;18(4):451-64.
molnova catalog



related products
-
Adrenosterone
Adrenosterone is a steroid hormone with weak androgenic effect.
-
GSK-2881078
A potent and selective androgen receptor modulator (SARM) for the treatment of cachexia.
-
RD162
RD162 is a second-generation, orally available antiandrogen that binds to androgen receptor (AR) with IC50 of 30.9 nM.